Nephros, Inc.
NEPH
$4.36
$0.307.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 36.16% | 6.87% | 22.20% | 35.42% | 35.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.16% | 6.87% | 22.20% | 35.42% | 35.89% |
| Cost of Revenue | 22.60% | 28.79% | 41.08% | 35.06% | 21.19% |
| Gross Profit | 44.04% | -5.10% | 11.56% | 35.64% | 46.18% |
| SG&A Expenses | 9.86% | 11.85% | 23.72% | 29.52% | 13.40% |
| Depreciation & Amortization | -17.14% | -25.64% | -5.88% | 0.00% | 2.94% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.18% | 18.65% | 32.59% | 34.36% | 16.87% |
| Operating Income | 389.11% | -82.86% | -94.32% | 52.43% | 178.23% |
| Income Before Tax | 391.87% | -74.91% | -82.97% | 85.79% | 185.12% |
| Income Tax Expenses | 44.44% | -- | -100.00% | -- | -- |
| Earnings from Continuing Operations | 405.06% | -74.91% | -82.23% | 84.15% | 182.01% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 405.06% | -74.91% | -82.23% | 84.15% | 182.01% |
| EBIT | 389.11% | -82.86% | -94.32% | 52.43% | 178.23% |
| EBITDA | 339.22% | -79.54% | -85.80% | 45.61% | 200.35% |
| EPS Basic | 392.41% | -75.10% | -82.48% | 82.76% | 181.45% |
| Normalized Basic EPS | 380.69% | -75.08% | -83.33% | 85.19% | 184.30% |
| EPS Diluted | 450.00% | -80.00% | -82.48% | 72.41% | 166.67% |
| Normalized Diluted EPS | 379.58% | -75.68% | -83.80% | 77.78% | 182.56% |
| Average Basic Shares Outstanding | 2.42% | 0.48% | 0.98% | 0.64% | 0.90% |
| Average Diluted Shares Outstanding | 2.77% | 3.53% | 6.15% | 4.35% | 2.88% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |